CSL BEHRING GENE THERAPY, INC. logo

CSL BEHRING GENE THERAPY, INC.

8 Marks
Corp.
First Filed:Aug 6, 2012Latest Filed:Jun 24, 2024Address:35 N. Lake Avenue, Pasadena, CA 91101, US

Portfolio Overview

Pending
5(63%)
Dead
3(38%)

Top Classes

Class 5
Pharmaceuticals
4(50%)
Class 40
Material Treatment
3(38%)
Class 1
Industrial Chemicals & Adhesives
2(25%)

TTAB Proceedings

No litigation activity

Top Firms

Smith, Gambrell & Russell, L...(Jun 2024)
6
Cooley LLP(Aug 2012)
1

Trademark Portfolio

8 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
CYTEGRITY
CYTEGRITY
Service Mark
Word
ITU
PENDING
Owner:
Serial:98615749
Filed:Jun 24, 2024
Classes:35, 40, 42
Goods & Services
Custom manufacture of pharmaceuticals based on cell therapy and gene therapy; Custom manufacture of medicine, namely, personalized medicine for others based on unique characteristics and conditions of the patient; Electronic data collection and data submission services for business purposes in the fields of medicine and healthcare; Research and development services relating to viral vectors, cell therapies, gene therapies, and medicines; Development of pharmaceutical preparations, viral vectors, cell therapies, gene therapies, and medicines; Stem cell research services; Stem cell gene therapy services, namely, advanced inducible stable producer technology research services designed specifically for the production of lentiviral vectors; Gene therapy research; Testing, inspection, research or development of pharmaceutical preparations for gene therapy
CYTEGRITY
CYTEGRITY
Trademark
Word
ITU
PENDING
Owner:
Serial:98232757
Filed:Oct 20, 2023
Classes:1, 5
Goods & Services
Cell lines for medical purposes; Cells for medical or clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating cancer, tumors, genetic diseases, immunodeficiency conditions, stem cell transplantation, and transplant medicine; Biological preparations, namely, viral vectors and gene therapy vectors for therapeutic use and clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for treating a wide range of diseases, illnesses or conditions; Cell lines for medical purposes, namely, cell therapy; Cell lines for medical purposes, namely, immunotherapy; Cell lines for medical purposes, namely, for use as therapeutics to repair, replace or preserve cells and tissues; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating genetically engineered tissues and for treating transplant conditions; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating viral and infectious diseases; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; viral vectors for medical use relating to gene therapy; gene therapy vectors for medical use; Cell lines, being cells, for scientific and research use; Cells for scientific, laboratory or medical research; Biological preparations, namely, viral vectors and gene vectors for scientific, laboratory or medical research; Cell lines for clinical laboratory use; cell lines for scientific research, namely, cell lines for gene expression and for the synthesis of biological compounds; cells for scientific, laboratory, or medical research, namely, cells for gene expression systems and for the synthesis of biological compounds; viral vectors for use in science and industry
CYTEGRITY
CYTEGRITY
Service Mark
Word
ITU
PENDING
Owner:
Serial:98232780
Filed:Oct 20, 2023
Classes:35, 40, 42, +1
Goods & Services
Biomanufacturing for others, namely, manufacturing of pharmaceuticals and of viral vectors and gene therapy vectors using biological organisms or viruses in the manufacturing process; custom manufacturing services of ex vivo, lentiviral stable cell lines; custom manufacturing services of lentiviral vectors by transient transfection; Biomanufacturing for others, namely, manufacturing of viral vectors and gene therapy vectors using biological organisms or viruses in the manufacturing process; biomanufacturing for others, namely, manufacturing of cell lines and cells using biological organisms or viruses in the manufacturing process; biomanufacturing for others, namely, manufacturing of biological preparations for use in industry and science, and cell cultures for medical purposes using biological organisms or viruses in the manufacturing process; Biomanufacturing process consulting; Business consultation in the field of business process improvement for clinical manufacturing; Regulatory compliance consulting in the field of clinical manufacturing; Scientific and pharmaceutical research and development; medical research; biological research; Scientific laboratory services in in the field of viral vectors and gene therapy vectors; Scientific, pharmaceutical, and medical research in the field of bioproduction, regulatory pathway services, accessory proteins and alternative envelope proteins; Scientific research consulting in the field of clinical manufacturing
GENECAPS
GENECAPS
Trademark
Word
ITU
PENDING
Owner:
Serial:97373693
Filed:Apr 21, 2022
Classes:5
Goods & Services
Non-viral vectors in the form of nanoscale matrices, namely, pharmaceutical preparations for the delivery of therapeutic agents for the treatment or prevention of diseases affecting the immune system or hematologic system; Non-viral vectors, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
SELECT+
SELECT+
Trademark
Word
ITU
PENDING
Owner:
Serial:88727403
Filed:Dec 14, 2019
Classes:5
Goods & Services
Chemoselective agents for gene therapy, namely for the treatment or prevention of diseases affecting the immune system or hematologic system
CYTEGRITY
CYTEGRITY
Trademark
Word
ABANDONED
Owner:
Serial:88583412
Filed:Aug 19, 2019
Classes:1
CYTEGRITY
CYTEGRITY
Service Mark
Word
CANCELLED
Owner:
Serial:86867368
Filed:Jan 6, 2016
Classes:40
Registration:5335997
Registered:Nov 14, 2017
CALIMMUNE
CALIMMUNE
Trademark
Word
CANCELLED
Owner:
Serial:85696441
Filed:Aug 6, 2012
Classes:5
Registration:4964811
Registered:May 24, 2016

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.